Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alabama to update PSE tracking system

This article was originally published in The Tan Sheet

Executive Summary

The Alabama state Senate March 9 passed a bill creating an electronic tracking system for sales of products with pseudoephedrine and ephedrine, precursors for methamphetamine. The bill, which awaits the governor's signature, modernizes paper logs that require retailers to record consumers' identifying information and purchases of PSE and ephedrine. The new system will notify retailers if a customer exceeds the sales limit for the drugs. Alabama is one of several states to require electronic tracking of PSE (1"The Tan Sheet" March 15, 2010, In Brief)

You may also be interested in...

Missouri tracks PSE sales

Missouri becomes the fourth state to track sales of OTC pseudoephedrine-containing medicines with the National Precursor Log Exchange, the Consumer Healthcare Products Association announces March 8. NPLEx is a real-time, statewide electronic log that helps block illegal sales of PSE, a precursor used to create methamphetamine. CHPA offers the system to states for free as an alternative to moving PSE products to Rx only. So far only Colorado and Mississippi switched OTC PSE drugs to Rx to curb illegal sales and meth production (1"The Tan Sheet" Feb. 8, 2010).... Washington Senate votes to track PSE sales: The Washington state Senate passes a bill March 12 directing the state Board of Pharmacy to establish an electronic tracking system for PSE, ephedrine and phenylpropanolamine products by next July. The bill also raises the daily sales limit for drugs containing meth precursors to 3.6 grams to match the federal limit. Previously, the bill capped the daily total at 3 grams or a single package of any product with the ingredients. A similar bill passed the state house previously

Deals Shaping The Medical Industry, January 2020

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2019.

AstraZeneca's Fredrickson On Its Cancer Ambitions

Just over a year ago, AstraZeneca at last returned to growth and set about a reorganization that placed oncology at the heart of its plans for continued success. In Vivo talked to the executive vice-president of its Oncology Business Unit David Fredrickson about how the company hopes to become a major cancer player.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts